Roche

News

Roche develops Bundibugyo Ebola test in six days

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.

R&D

The changing multiple sclerosis landscape: Earlier diagnosis...

Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed.

News

Roche launches liver disease algorithm panel

Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with chronic liver disease.

News

Regenxbio's Duchenne gene therapy clears phase 3 hurdle

Regenxbio is pitching at FDA approval in 2027 for its Duchenne muscular dystrophy gene therapy RGX-202, a potential rival to Sarepta/Roche's Elevidys.

News

Roche buys AI-powered diagnostics player PathAI

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.

News

Swiss franc strength puts Roche's results in a poor light

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.

Roche develops Bundibugyo Ebola test in six days

The changing multiple sclerosis landscape: Earlier diagnosis...

Roche launches liver disease algorithm panel

Regenxbio's Duchenne gene therapy clears phase 3 hurdle

Roche buys AI-powered diagnostics player PathAI

Swiss franc strength puts Roche's results in a poor light

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks